Unexploited Antineoplastic Effects of Commercially Available Anti-Diabetic Drugs
about
Use of an anti-viral drug, Ribavirin, as an anti-glioblastoma therapeutic.Marketed drugs used for the management of hypercholesterolemia as anticancer armament.Targeted Therapies: Immunologic Effects and Potential Applications Outside of Cancer.Opposing roles of the aldo-keto reductases AKR1B1 and AKR1B10 in colorectal cancer.Metformin and blood cancersPleiotropic Effects of Metformin on Cancer
P2860
Unexploited Antineoplastic Effects of Commercially Available Anti-Diabetic Drugs
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Unexploited Antineoplastic Effects of Commercially Available Anti-Diabetic Drugs
@ast
Unexploited Antineoplastic Effects of Commercially Available Anti-Diabetic Drugs
@en
Unexploited Antineoplastic Effects of Commercially Available Anti-Diabetic Drugs
@nl
type
label
Unexploited Antineoplastic Effects of Commercially Available Anti-Diabetic Drugs
@ast
Unexploited Antineoplastic Effects of Commercially Available Anti-Diabetic Drugs
@en
Unexploited Antineoplastic Effects of Commercially Available Anti-Diabetic Drugs
@nl
prefLabel
Unexploited Antineoplastic Effects of Commercially Available Anti-Diabetic Drugs
@ast
Unexploited Antineoplastic Effects of Commercially Available Anti-Diabetic Drugs
@en
Unexploited Antineoplastic Effects of Commercially Available Anti-Diabetic Drugs
@nl
P2093
P2860
P3181
P356
P1433
P1476
Unexploited Antineoplastic Effects of Commercially Available Anti-Diabetic Drugs
@en
P2093
Maria Tsironi
Panagiota Papanagnou
Theodora Stivarou
P2860
P3181
P356
10.3390/PH9020024
P407
P577
2016-01-01T00:00:00Z